Based on data collected from different sources by our team,
there are indicators that suggest that this company is no longer active. However, this information may not be accurate.
If you believe this information should be updated, please .
For more details, you can read our .
12/2021 ceased to operate
Skintelligence
Skintelligence Overview
Skintelligence is the developer of clinical decision support systems (CDSSs) designed to predict an individuals response to biological therapy, specifically in the treatment of autoimmune diseases such as psoriasis, rheumatoid arthritis, and Crohns disease. The companys solution enables physicians to prescribe biological medication while avoiding the typical process of trial and error, thereby reducing both the high cost of biological treatments and the patients discomfort.
Skintelligences CDSSs are based on artificial intelligence tools that enable the compilation of information fundamental to predicting a patients response to therapy. The companys patented SmartPAD (SMART Predictor for Autoimmune Diseases) comprises a device that measures immunologic biomarkers from the skin using non-invasive assays and software that integrates the biomarkers from the skin with clinical data to calculate the probability of treatment success with each of the commercial biological drugs.